* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Chapter 16 Cholinesterase Inhibitors
Survey
Document related concepts
Discovery and development of beta-blockers wikipedia , lookup
Discovery and development of neuraminidase inhibitors wikipedia , lookup
Discovery and development of integrase inhibitors wikipedia , lookup
Metalloprotease inhibitor wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Drug interaction wikipedia , lookup
Neuropharmacology wikipedia , lookup
Psychopharmacology wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Discovery and development of ACE inhibitors wikipedia , lookup
Transcript
Chapter 44 Drugs Acting on the ReninAngiotensin-Aldosterone System Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Drugs Acting on the ReninAngiotensin-Aldosterone System Physiology of the renin-angiotensinaldosterone system Angiotensin-converting enzyme inhibitors Angiotensin II receptor blockers Aldosterone antagonists Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 2 Physiology of the ReninAngiotensin-Aldosterone System Type of angiotensin Angiotensin I Angiotensin II Angiotensin III Actions of angiotensin II Vasoconstriction Release of aldosterone Alteration of cardiac and vascular structure Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 3 Physiology of the ReninAngiotensin-Aldosterone System Actions of aldosterone Regulation of blood volume and blood pressure Pathologic cardiovascular effects Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 4 Fig. 44–1. Regulation of blood pressure by the renin-angiotensin-aldosterone system. Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 5 Physiology of the ReninAngiotensin-Aldosterone System Formation of angiotensin II by renin and angiotensin-converting enzyme (ACE) Renin • Catalyzes the formation of angiotensin I from angiotensinogen • Regulation of renin release Angiotensin-converting enzyme (kinase II) • Catalyzes the conversion of angiotensin I (inactive) to angiotensin II (highly active) Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 6 Physiology of the ReninAngiotensin-Aldosterone System Regulation of blood pressure by the reninangiotensin-aldosterone system Helps regulate blood pressure in the presence of hemorrhage, dehydration, or sodium depletion Acts in two ways • Constricts renal blood vessels • Acts on the kidney to promote retention of sodium and water and excretion of potassium Tissue (local) angiotensin II production Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 7 Angiotensin-Converting Enzyme Inhibitors Mechanism of action and overview of pharmacologic effects Reducing levels of angiotensin II Increasing levels of bradykinin Pharmacokinetics Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 8 Angiotensin-Converting Enzyme Inhibitors Therapeutic uses Hypertension Heart failure Myocardial infarction (MI) Diabetic and nondiabetic nephropathy Prevention of MI, stroke, and death in patients at high cardiovascular risk MI = myocardial infarction. Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 9 Fig. 44–2. Overview of ACE inhibitor actions and pharmacologic effects. Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 10 Angiotensin-Converting Enzyme Inhibitors Adverse effects First-dose hypotension Fetal injury Cough Angioedema Hyperkalemia Dysgeusia and rash Renal failure Neutropenia Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 11 Angiotensin-Converting Enzyme Inhibitors Drug interactions Diuretics Antihypertensive agents Drugs that raise potassium levels Lithium Nonsteroidal anti-inflammatory drugs Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 12 Angiotensin-Converting Enzyme Inhibitors Preparations, dosage, and administration Except for enalaprilat, all ACE inhibitors are administered orally All available in single-drug formulations Except for captopril and moexipril, all oral formulations may be administered without regard to meals Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 13 Angiotensin II Receptor Blockers Mechanism of action and overview of pharmacologic effects Block access of angiotensin II Cause dilation of arterioles and veins Prevent angiotensin II from inducing pathologic changes in cardiac structure Reduce excretion of potassium Decrease release of aldosterone Increase renal excretion of sodium and water Do not inhibit kinase II Do not increase levels of bradykinin Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 14 Fig. 44–3. Elevation of glomerular filtration pressure by angiotensin II. Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 15 Angiotensin II Receptor Blockers Therapeutic uses Hypertension, heart failure, myocardial infarction Diabetic nephropathy If unable to tolerate ACE inhibitors: protection against MI, stroke, and death from cardiovascular (CV) causes in high-risk patients Migraine headache May prevent development of diabetic retinopathy New data show that ACE inhibitors and angiotensin II receptor blockers (ARBs) are not effective for primary prevention of nephropathy in normotensive diabetic patients Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 16 Angiotensin II Receptor Blockers Adverse effects Angioedema Fetal harm Renal failure Possibility of promoting cancer Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 17 Direct Renin Inhibitors Aliskiren (Tekturna) Binds tightly with renin and inhibits the cleavage of angiotensinogen to angiotensin I Side effects • Angioedema, cough, GI effects, hyperkalemia, fetal injury, and death Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 18 Aldosterone Antagonists Eplerenone (Inspra) Mechanism of action • Selective blockade of aldosterone receptors Therapeutic uses • Hypertension • Heart failure Pharmacokinetics • Absorption is not affected by food Adverse effects • Hyperkalemia Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 19 Aldosterone Antagonists Eplerenone (Inspra) (cont’d) Drug interactions • Inhibitors of CYP3A4 • Drugs that raise potassium levels • Use with caution when combined with lithium Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 20 Aldosterone Antagonists Spironolactone (Aldactone) Mechanism of action • Blocks aldosterone receptors • Binds with receptors for other steroid hormones Therapeutic uses • Hypertension • Heart failure Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 21 Aldosterone Antagonists Spironolactone (Aldactone) (cont’d) Adverse effects • Hyperkalemia • Gynecomastia • Menstrual irregularities • Impotence • Hirsutism • Deepening of the voice Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 22